Carlyle Group’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-192,884
| Closed | -$55.9K | – | 33 |
|
|
2024
Q2 | $55.9K | Hold |
192,884
| – | – | 0.01% | 30 |
|
|
2024
Q1 | $2.72M | Sell |
192,884
-1
| -0% | -$14 | 0.17% | 19 |
|
|
2023
Q4 | $2.23M | Hold |
192,885
| – | – | 0.11% | 20 |
|
|
2023
Q3 | $2.87M | Hold |
192,885
| – | – | 0.12% | 21 |
|
|
2023
Q2 | $3.95M | Hold |
192,885
| – | – | 0.14% | 20 |
|
|
2023
Q1 | $1.69M | Buy |
+192,885
| New | +$1.69M | 0.05% | 24 |
|